[go: up one dir, main page]

BR9611521A - Antagonistas de receptor de aminoácido excitador - Google Patents

Antagonistas de receptor de aminoácido excitador

Info

Publication number
BR9611521A
BR9611521A BR9611521A BR9611521A BR9611521A BR 9611521 A BR9611521 A BR 9611521A BR 9611521 A BR9611521 A BR 9611521A BR 9611521 A BR9611521 A BR 9611521A BR 9611521 A BR9611521 A BR 9611521A
Authority
BR
Brazil
Prior art keywords
amino acid
receptor antagonists
acid receptor
exciting amino
exciting
Prior art date
Application number
BR9611521A
Other languages
English (en)
Inventor
Carmen Dominguez-Fernandez
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605430.9A external-priority patent/GB9605430D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9611521A publication Critical patent/BR9611521A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/45Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C255/47Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of rings being part of condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/18All rings being cycloaliphatic the ring system containing six carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BR9611521A 1995-11-16 1996-11-12 Antagonistas de receptor de aminoácido excitador BR9611521A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US687195P 1995-11-16 1995-11-16
GBGB9605430.9A GB9605430D0 (en) 1996-03-15 1996-03-15 Excitatory amino acid receptor antagonists
PCT/US1996/018207 WO1997017950A1 (en) 1995-11-16 1996-11-12 Shoulder prosthesis

Publications (1)

Publication Number Publication Date
BR9611521A true BR9611521A (pt) 1999-06-29

Family

ID=26308934

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611521A BR9611521A (pt) 1995-11-16 1996-11-12 Antagonistas de receptor de aminoácido excitador

Country Status (13)

Country Link
EP (1) EP0774455A1 (pt)
JP (1) JP2000500752A (pt)
KR (1) KR19990067597A (pt)
CN (1) CN1202103A (pt)
AR (2) AR004600A1 (pt)
AU (1) AU703093B2 (pt)
BR (1) BR9611521A (pt)
CA (1) CA2237598A1 (pt)
CO (1) CO4750811A1 (pt)
EA (1) EA000894B1 (pt)
TW (1) TW427973B (pt)
WO (1) WO1997017950A1 (pt)
YU (1) YU60896A (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157594B2 (en) 2001-12-27 2007-01-02 Taisho Pharmaceutical Co., Ltd. 6-Fluorobicyclo[3.1.0]hexane derivatives

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825211B1 (en) 1997-07-18 2004-11-30 Georgetown University Bicyclic metabotropic glutamate receptor ligands
JP2001515839A (ja) * 1997-07-18 2001-09-25 ジョージタウン・ユニバーシティ 二環式向代謝性グルタミン酸受容体リガンド
CN1231461C (zh) * 1998-03-17 2005-12-14 辉瑞产品公司 二环并[2.2.1]庚烷和有关化合物
SI1064256T1 (en) * 1998-03-17 2004-10-31 Pfizer Products Inc. Bicyclo (2.2.1) heptanes and related compounds
PT1110943E (pt) 1998-08-31 2004-08-31 Taisho Pharmaceutical Co Ltd Derivados 6-fluorobiciclo¬3.1.0|hexano
CH694053A5 (de) * 1998-09-03 2004-06-30 Hoffmann La Roche Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten.
US8138377B2 (en) * 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
AR083845A1 (es) 2010-11-18 2013-03-27 Lilly Co Eli COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR2/3
WO2012068041A1 (en) 2010-11-18 2012-05-24 Eli Lilly And Company 4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3981880A (en) * 1969-03-14 1976-09-21 The Upjohn Company Racemic prostaglandins of the 2-series and analogs thereof
CA1278577C (en) * 1985-11-18 1991-01-02 Tatsuo Tsuri Bicyclic sulfonamide derivatives
PL182285B1 (pl) 1994-08-12 2001-12-31 Lilly Co Eli Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL
ATE206915T1 (de) * 1994-08-12 2001-11-15 Lilly Co Eli Behandlung von angstzuständen
EP0776200A4 (en) * 1994-08-12 2001-01-17 Lilly Co Eli AGENT AND METHOD FOR PROTECTING DRUG ADDICTION

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157594B2 (en) 2001-12-27 2007-01-02 Taisho Pharmaceutical Co., Ltd. 6-Fluorobicyclo[3.1.0]hexane derivatives

Also Published As

Publication number Publication date
JP2000500752A (ja) 2000-01-25
AU7731096A (en) 1997-06-05
CA2237598A1 (en) 1997-05-22
AR004600A1 (es) 1998-12-16
AR004601A1 (es) 1998-12-16
CN1202103A (zh) 1998-12-16
YU60896A (sh) 1998-12-23
KR19990067597A (ko) 1999-08-25
AU703093B2 (en) 1999-03-18
WO1997017950A1 (en) 1997-05-22
EP0774455A1 (en) 1997-05-21
CO4750811A1 (es) 1999-03-31
EA000894B1 (ru) 2000-06-26
TW427973B (en) 2001-04-01
EA199800380A1 (ru) 1998-10-29

Similar Documents

Publication Publication Date Title
FI933810A7 (fi) Virittyvien aminohappojen reseptoriantagonisteja
NO972016D0 (no) Indolyl-Y-reseptorantagonister
DK0878463T3 (da) Excitatoriske aminosyrereceptormodulatorer
DE69833073D1 (de) CCR-3-Rezeptor-Antagonisten
EP0810994A4 (en) FIBRINOGEN RECEPTOR ANTAGONISTS
FI945704A7 (fi) Eksitatorisen aminohapporeseptorin antagonisteja
ZA969485B (en) Excitatory amino acid receptor antagonists.
DK1009732T3 (da) 1-Amino-alkylcyclohexan NMDA receptor antagonister
DE69812096D1 (de) Neuropeptid y rezeptorantagonisten
FI955223L (fi) Adheesioreseptoriantagonisteja
DE69734833D1 (de) Vitronektin rezeptor antagonisten
EP0866705A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
ATE258548T1 (de) Adhäsionsrezeptor-antagonisten
ID16742A (id) Antagonis reseptor endotelin
BR9611509A (pt) Antagonistas de receptores de aminoácidos excitativos
EP0885205A4 (en) Fibrinogen Receptor Antagonists
FI960516L (fi) Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja
FI903183A7 (fi) Eksitatorisen aminohapporeseptorin tetratsoliantagonisteja
ID24726A (id) Antagonis-antagonis reseptor trombin
NO950606D0 (no) Adhesjonsreseptor-antagonister
ID24162A (id) Antagonis-antagonis reseptor vitronektin
EP0929218A4 (en) P2Y RECEPTOR ANTAGONISTS
FI955351A7 (fi) Tarttumisreseptoriantagonistit
BR9611521A (pt) Antagonistas de receptor de aminoácido excitador
DE69513832D1 (de) Exzitatorische aminosäure-rezeptor-antagonisten

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law